Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 41.98B | 41.36B | 38.63B | 37.24B | 32.54B |
Gross Profit | 12.65B | 13.16B | 12.24B | 11.22B | 9.95B |
EBITDA | 3.67B | 3.96B | 3.91B | 4.27B | 3.20B |
Net Income | 1.20B | 1.48B | 1.67B | 2.19B | 1.53B |
Balance Sheet | |||||
Total Assets | 47.01B | 47.83B | 43.63B | 40.54B | 37.68B |
Cash, Cash Equivalents and Short-Term Investments | 6.53B | 8.88B | 6.60B | 6.66B | 5.63B |
Total Debt | 9.62B | 11.42B | 9.14B | 8.60B | 8.55B |
Total Liabilities | 20.88B | 22.51B | 19.04B | 17.37B | 16.55B |
Stockholders Equity | 25.44B | 24.73B | 23.73B | 22.34B | 20.37B |
Cash Flow | |||||
Free Cash Flow | 1.12B | 1.42B | 110.17M | 1.46B | -202.23M |
Operating Cash Flow | 1.71B | 2.62B | 1.68B | 2.74B | 836.88M |
Investing Cash Flow | -410.03M | -1.44B | -1.69B | -1.15B | -2.21B |
Financing Cash Flow | -3.38B | 808.50M | -517.24M | -900.07M | 685.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥19.19B | 16.35 | 4.78% | 1.50% | -18.81% | ||
63 Neutral | $34.72B | 5.19 | -11.20% | 1.67% | 5.59% | -16.73% | |
― | €910.00M | 8.21 | 10.70% | 6.10% | ― | ― | |
80 Outperform | ¥14.66B | 8.27 | 2.79% | -1.59% | -6.38% | ||
78 Outperform | ¥39.64B | 15.57 | 2.39% | -15.98% | -51.13% | ||
72 Outperform | ¥28.59B | 6.70 | 6.03% | -10.85% | 25.59% | ||
71 Outperform | ¥18.74B | 5.12 | 4.53% | 21.35% | 221.66% |